GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Krynica Vitamin KVT.WA · PLN

Consumer Staples · GPW · 🇵🇱 Poland

Compare

12.85

0.00%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in PLN, from our data supplier.

FY2025

Revenue

PLN 356.3m

FY2016FY2025

Net income

PLN 12.0m

FY2016FY2025

Free cash flow

PLN 22.7m

FY2016FY2025

Shareholders' equity

PLN 102.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenuePLN 356.3mPLN 387.9mPLN 359.2mPLN 377.2mPLN 395.3mPLN 445.9mPLN 296.8mPLN 269.3mPLN 206.9mPLN 166.7m
Research and development——PLN 499,000——PLN 83,000—PLN 780,000PLN 831,000PLN 882,000
Operating incomePLN 14.2mPLN 16.8m−PLN 3.0mPLN 16.7mPLN 20.5mPLN 74.4mPLN 10.6mPLN 8.1mPLN 7.6mPLN 3.9m
Net incomePLN 12.0mPLN 12.2m−PLN 6.7mPLN 13.1mPLN 15.6mPLN 56.6mPLN 7.1mPLN 5.0mPLN 5.7mPLN 2.6m
Diluted earnings per share0.981.00-0.551.071.274.620.580.410.470.21

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsPLN 188.3mPLN 224.3mPLN 227.6mPLN 233.1mPLN 227.3mPLN 210.4mPLN 172.3mPLN 151.5mPLN 133.3mPLN 123.6m
Cash and short-term investmentsPLN 260,000PLN 214,000PLN 2.5mPLN 770,000PLN 2.1mPLN 6.3mPLN 760,000PLN 577,000PLN 675,000PLN 200,000
Total liabilitiesPLN 85.6mPLN 130.3mPLN 145.8mPLN 142.1mPLN 149.5mPLN 125.9mPLN 117.3mPLN 95.5mPLN 78.9mPLN 71.2m
DebtPLN 29.7mPLN 49.3mPLN 65.5mPLN 70.9mPLN 61.7mPLN 37.5mPLN 60.1mPLN 41.3mPLN 29.7mPLN 32.7m
Shareholders' equityPLN 102.7mPLN 94.0mPLN 81.8mPLN 90.9mPLN 77.9mPLN 80.5mPLN 55.0mPLN 56.0mPLN 54.4mPLN 52.4m
Shares outstanding12m12m12m12m12m12m12m12m12m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsPLN 28.5mPLN 31.0mPLN 21.5mPLN 14.4mPLN 13.6mPLN 74.3mPLN 19.1mPLN 23.3mPLN 10.0mPLN 15.0m
Capital spending−PLN 5.8m−PLN 10.8m−PLN 10.5m−PLN 16.1m−PLN 21.0m−PLN 16.2m−PLN 17.1m−PLN 31.3m−PLN 7.5m−PLN 17.8m
Free cash flowPLN 22.7mPLN 20.2mPLN 11.0m−PLN 1.8m−PLN 7.4mPLN 58.1mPLN 2.0m−PLN 8.0mPLN 2.5m−PLN 2.8m
Dividends paid−PLN 3.3m—−PLN 2.5m—−PLN 18.0m−PLN 27.4m−PLN 8.1m−PLN 2.9m−PLN 2.1m−PLN 9.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenuePLN 119.0mPLN 85.3mPLN 68.5mPLN 100.8mPLN 107.4mPLN 79.6mPLN 86.3mPLN 112.9m
Operating incomePLN 9.4mPLN 1.8m−PLN 1.9mPLN 7.0mPLN 8.8mPLN 715,000PLN 314,000PLN 8.5m
Net incomePLN 4.9mPLN 830,000−PLN 310,000PLN 5.0mPLN 6.3mPLN 924,000PLN 711,000PLN 6.6m
Diluted earnings per share0.400.07-0.030.410.520.080.060.54
Cash from operations−PLN 3.0mPLN 11.0mPLN 10.0m—PLN 8.0mPLN 10.0m−PLN 3.0mPLN 13.0m
Capital spending−PLN 1.0m−PLN 6.0m−PLN 2.0m−PLN 1.0m−PLN 1.0m−PLN 1.0m−PLN 5.0m−PLN 1.0m
Free cash flow−PLN 4.0mPLN 5.0mPLN 8.0m—PLN 7.0mPLN 9.0m−PLN 8.0mPLN 12.0m
Total assetsPLN 246.9mPLN 227.0mPLN 188.3mPLN 207.2mPLN 237.5mPLN 220.8mPLN 224.3mPLN 230.4m
Cash and short-term investmentsPLN 11.3mPLN 6.8mPLN 260,000PLN 70,000PLN 15.3mPLN 48,000PLN 214,000PLN 3.9m
DebtPLN 30.7mPLN 28.7mPLN 30.2mPLN 33.7mPLN 35.4mPLN 34.9mPLN 42.4mPLN 34.7m
Shareholders' equityPLN 100.8mPLN 103.5mPLN 102.7mPLN 103.0mPLN 98.0mPLN 95.0mPLN 94.0mPLN 93.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.9%-4.4%8.0%
Operating income-5.2%-28.2%-2.4%
Net income-3.0%-26.7%-1.3%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin4.2%3.0%6.0%5.5%
Net margin3.2%2.1%4.4%4.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings10.88.1-25.212.213.74.29.120.48.536.9
Price to sales0.40.30.50.40.50.50.20.40.20.6

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 10 Jul 2025.

FY2025FY2023FY2021FY2020FY2019FY2018FY2017FY2016
Paid in the year0.270.201.472.240.660.240.170.74

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.